No registrations found.
ID
Source
Health condition
Muscle mass growth; which can be related to sarcopenia
Sponsors and support
Intervention
Outcome measures
Primary outcome
Muscle protein synthesis
Secondary outcome
Plasma amino acid concentrations
Background summary
Eggs are considered as a conventional “high-quality” dietary protein source as they contain all of the essential amino acids (EAA) and are highly digestible. Hence, the ingestion of eggs has been shown to stimulate skeletal muscle protein synthesis and is therefore considered as an optimal protein source to ingest after exercise. Eggs are generally boiled before consumption. However, they can also be ingested in other ways (e.g., raw). There is a lack of information in the way eggs might differ in their potential to stimulate skeletal muscle protein synthesis when ingested either boiled or raw. Therefore, the aim of the present study is to assess the capacity of egg protein either boiled or raw in stimulating post-exercise skeletal muscle protein synthesis and support protein anabolism in vivo in humans.
Study objective
We hypothesize that the ingestion of boiled eggs will lead to significant higher rates of muscle protein synthesis compared to raw egg ingestion or a low-protein control meal.
Study design
Muscle biopsies will be taken at timepoints: 0, 2, 5 h after ingestion of the eggs or control meal
Intervention
Effect of raw vs boiled eggs ingestion vs low-protein control meal after exercise on muscle protein synthesis
Cas Fuchs
Maastricht
The Netherlands
0433881381
cas.fuchs@maastrichtuniversity.nl
Cas Fuchs
Maastricht
The Netherlands
0433881381
cas.fuchs@maastrichtuniversity.nl
Inclusion criteria
Healthy males
Age between 18 and 35 y inclusive
BMI between 18.5 and 30 kg/m2
Exclusion criteria
Allergies to egg proteins
Smoking
Phenylketonuria
Diabetes Mellitus
Diagnosed GI tract disorders or diseases
Arthritic conditions
A history of neuromuscular problems
Any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
Use of certain anticoagulants (use of thrombocyte
aggregation inhibitors such as acetylsalicylic acid and carbasalaatcalcium is permitted. Use of
other thrombocyte aggregation inhibitors will be discussed with the responsible physician)
Blood donation within 2 months of study initiation
Hypertension (according to WHO criteria)
Design
Recruitment
IPD sharing statement
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL6506 |
NTR-old | NTR6694 |
Other | METC azM/UM : METC173030 |